-+ 0.00%
-+ 0.00%
-+ 0.00%

TENAYA THERAPEUTICS GRANTED U.S. FDA REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR TN-401 FOR THE TREATMENT OF PKP2-ASSOCIATED ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

Reuters·09/14/2026 12:30:00

Please log in to view news